APA (7th ed.) Citation

Rawson, R., Maher, N., Menzies, A., Lo, S., Mesbah Ardakani, N., Jackett, L., . . . Khattak, M. (2026). Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma. Annals of Oncology, 37(2), 206. https://doi.org/10.1016/j.annonc.2025.10.1237

Chicago Style (17th ed.) Citation

Rawson, R.V, et al. "Pathological Response Calculation Assessment Remains Accurate with Reduced Tumor Bed Examination After Neoadjuvant Immunotherapy in Clinically Detectable Stage III Melanoma." Annals of Oncology 37, no. 2 (2026): 206. https://doi.org/10.1016/j.annonc.2025.10.1237.

MLA (9th ed.) Citation

Rawson, R.V, et al. "Pathological Response Calculation Assessment Remains Accurate with Reduced Tumor Bed Examination After Neoadjuvant Immunotherapy in Clinically Detectable Stage III Melanoma." Annals of Oncology, vol. 37, no. 2, 2026, p. 206, https://doi.org/10.1016/j.annonc.2025.10.1237.